103 related articles for article (PubMed ID: 26408874)
1. Parmacokinetic evaluation of ibuprofen controlled release matrix tablets using hydrophilic Eudragit® polymer and co-excipients.
Bakhsh S; Khan GM; Menaa F; Khan BA
Pak J Pharm Sci; 2015 Sep; 28(5):1745-55. PubMed ID: 26408874
[TBL] [Abstract][Full Text] [Related]
2. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
Jan SU; Khan GM; Hussain I
Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
Patel N; Madan P; Lin S
Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
[TBL] [Abstract][Full Text] [Related]
4. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
Le TC; Mateescu MA
Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
[TBL] [Abstract][Full Text] [Related]
5. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
[TBL] [Abstract][Full Text] [Related]
6. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug.
Khan GM; Jiabi Z
J Control Release; 1998 Jul; 54(2):185-90. PubMed ID: 9724905
[TBL] [Abstract][Full Text] [Related]
7. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Once Daily Controlled-release Ibuprofen Matrix Tablets Prepared using Eudragit
Obeidat WM; Al-Natour MA
Curr Drug Deliv; 2022; 19(1):74-85. PubMed ID: 34176461
[TBL] [Abstract][Full Text] [Related]
9. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
Ruckmani K; Muneera MS; Vijaya R
Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
[TBL] [Abstract][Full Text] [Related]
10. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
11. Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen.
Cilurzo F; Minghetti P; Casiraghi A; Tosi L; Pagani S; Montanari L
Eur J Pharm Biopharm; 2005 May; 60(1):61-6. PubMed ID: 15848057
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation.
Mumuni M; Kenechukwu FC; Chime SA; Ogbonna JD; Mora AT
Drug Deliv; 2014 Jun; 21(4):315-9. PubMed ID: 24191762
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
14. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
15. Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen.
Potthast H; Dressman JB; Junginger HE; Midha KK; Oeser H; Shah VP; Vogelpoel H; Barends DM
J Pharm Sci; 2005 Oct; 94(10):2121-31. PubMed ID: 16136567
[TBL] [Abstract][Full Text] [Related]
16. Formulation and Evaluation of Hydroxypropyl Methylcellulose-based Controlled Release Matrix Tablets for Theophylline.
Sekharan TR; Palanichamy S; Tamilvanan S; Shanmuganathan S; Thirupathi AT
Indian J Pharm Sci; 2011 Jul; 73(4):451-6. PubMed ID: 22707833
[TBL] [Abstract][Full Text] [Related]
17. Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives.
Rebouh S; Lefnaoui S; Bouhedda M; Yahoum MM; Hanini S
Drug Deliv Transl Res; 2019 Feb; 9(1):162-177. PubMed ID: 30341764
[TBL] [Abstract][Full Text] [Related]
18. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
Möller T; Korsatko W
Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
[TBL] [Abstract][Full Text] [Related]
19. Design of prolonged release tablets using new solid acrylic excipients for direct compression.
Villanova JC; Ayres E; Oréfice RL
Eur J Pharm Biopharm; 2011 Nov; 79(3):664-73. PubMed ID: 21827852
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.
Khan KA; Khan GM; Jan SU; Rehman A; Mehsud S
Pak J Pharm Sci; 2018 Mar; 31(2):455-461. PubMed ID: 29618434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
